Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2005-06-07
2005-06-07
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
C514S114000
Reexamination Certificate
active
06903080
ABSTRACT:
A method of treating protozoal and fungal diseases is described, in which an effective amount of a compound of formula I is administered to a host having a protozoal or fungal disease. Also described are methods of treating bone marrow damage composed of administering, to a host having bone marrow damage due to treatment with cytostatic agents or other myelotoxic active ingredients, an effective amount of a compound of formula I
REFERENCES:
patent: 4444766 (1984-04-01), Bosies et al.
patent: 4542219 (1985-09-01), Huzumi
patent: 4778788 (1988-10-01), Munder
patent: 4935520 (1990-06-01), Najima
patent: 5049552 (1991-09-01), Eibl
patent: 5053402 (1991-10-01), Masaki
patent: 5183811 (1993-02-01), Masaki
patent: 2011209 (1990-04-01), None
patent: 35 30 767 (1987-03-01), None
patent: 36 41 379 (1987-09-01), None
patent: 39 06 952 (1990-09-01), None
patent: 39 42 933 (1991-06-01), None
patent: 41 14 586 (1992-11-01), None
patent: 1241994 (1986-06-01), None
patent: 1376948 (1988-02-01), None
E Aboud-Pirak, E Hurwitz, F Bellot, J Schlessinger, and M Sela, Proc Natl Acad Sci U S A. May 1989; 86 (10): 3778-3781.
P. Hilgard , T. Klenner, J. Stekar, G. Nössner, B. Kutscher and J. Engel, European Journal of Cancer vol. 33, Issue 3 , Mar. 1997, pp. 442-446.
Polman, C.H. et al, BMJ 2000, 321, 490-4.
Cohen, J.A. et al, J. Neuroimmun., 1999, 98 29-36.
Yanapirut, et al., “In vitro Investigations on the Antineoplastic Effect of Hexadecylphosphocholine,”Arzneim.-Forsch./Drug Res., 41 (1), No. 6, 1991, pp. 652-655.
Isselbachen et al.,Harrison's Principles of Internal Medicine, 13thed. (1994), vol. 2, pp. 1826-1829.
Wyngaarden et al.,Cecil Textbook of Medicine, 19thed. (1992), pp. 1049-1053.
Berkow et al.,The Merck Manual, 15thEd. (1987), pp. 1226-1227.
Polman et al.,BMJ2000, vol. 321, pp. 490-494.
Cohen et al.,J. Neuroimmun., vol. 98, 1999, pp. 29-36.
Fields et al.,Fields Virology, vol. 1, 3rdEd., 1996, p. 431.
Hawley,The Condensed Chemical Dictionary, 9thEd., 1977, pp. 27 and 650.
Engel Jurgen
Hilgard Peter
Kutscher Bernhard
Nossner Gerhard
Schumacher Wolfgang
McKenzie Thomas C.
Wilson James O.
Zentaris GmbH
LandOfFree
Disease treatment with novel phospholipid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Disease treatment with novel phospholipid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Disease treatment with novel phospholipid derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3520895